Harbor Capital Advisors’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-279,820
Closed -$1.78M 731
2024
Q1
$1.78M Sell
279,820
-28,682
-9% -$179K 0.23% 101
2023
Q4
$1.99M Buy
308,502
+22,437
+8% +$85.6K 0.38% 66
2023
Q3
$667K Buy
286,065
+41,524
+17% +$118K 0.14% 178
2023
Q2
$582K Buy
244,541
+22,392
+10% +$53.1K 0.12% 208
2023
Q1
$409K Buy
222,149
+76,834
+53% +$150K 0.12% 158
2022
Q4
$276K Sell
145,315
-3,139
-2% -$7.94K 0.27% 74
2022
Q3
$318K Sell
148,454
-16,452
-10% -$48.7K 0.29% 71
2022
Q2
$467K Buy
164,906
+1,763
+1% +$5.37K 0.36% 69
2022
Q1
$680K Sell
163,143
-48,176
-23% -$203K 0.32% 73
2021
Q4
$1.1M Buy
+211,319
New +$1.27M 0.4% 68

Other funds holding AUTL